Flavia Pease

Incoming Chief Financial Officer

CFO Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Insulet Corp (PODD)	Executive Vice President, Chief Financial Officer	$148,500	$650,000	$3,582,414	$194,229	$249,693	$335,925	$5,160,761
2024	Charles River Laboratories International, Inc. (CRL)	Corporate Executive Vice President, Chief Financial Officer	$645,190	—	$1,775,048	$448,997	$184,271	$100,740	$3,154,246
2023	Charles River Laboratories International, Inc. (CRL)	Corporate Executive Vice President, Chief Financial Officer	$621,915	$600,000	$1,722,601	$432,719	$324,223	$109,867	$3,811,326
2022	Charles River Laboratories International, Inc. (CRL)	Corporate Executive Vice President, Chief Financial Officer	$403,844	$200,000	$2,883,429	$828,323	$159,430	$9,124	$4,484,150

Executive changes

Resigned Corporate Executive Vice President, Chief Financial Officer at Charles River Laboratories International, Inc. (CRL)
2025-09-29
Appointed Class II director at Insulet Corp (PODD)
2024-01-18

Earnings-call appearances

Q2 2026 Insulet Corporation Earnings Call
Insulet Corp (PODD)

2026-08-05
Insulet Corp Q1 FY2026 Earnings Call
Insulet Corp (PODD)

2026-05-06
Insulet Corp Q4 FY2025 Earnings Call
Insulet Corp (PODD)

2026-02-18
Insulet Corp Q3 FY2025 Earnings Call
Insulet Corp (PODD)

2025-11-06
Charles River Laboratories International, Inc. Q2 FY2025 Earnings Call
Charles River Laboratories International, Inc. (CRL)

2025-08-06
Charles River Laboratories International, Inc. Q1 FY2025 Earnings Call
Charles River Laboratories International, Inc. (CRL)

2025-05-07
Charles River Laboratories International, Inc. Q4 FY2024 Earnings Call
Charles River Laboratories International, Inc. (CRL)

2025-02-19
Charles River Laboratories International, Inc. Q3 FY2024 Earnings Call
Charles River Laboratories International, Inc. (CRL)

2024-11-06
Charles River Laboratories International, Inc. Q2 FY2024 Earnings Call
Charles River Laboratories International, Inc. (CRL)

2024-08-07
Charles River Laboratories International, Inc. Q1 FY2024 Earnings Call
Charles River Laboratories International, Inc. (CRL)

2024-05-09
Charles River Laboratories International, Inc. Q4 FY2023 Earnings Call
Charles River Laboratories International, Inc. (CRL)

2024-02-14
Charles River Laboratories International, Inc. Q3 FY2023 Earnings Call
Charles River Laboratories International, Inc. (CRL)

2023-11-08
Charles River Laboratories International, Inc. Q2 FY2023 Earnings Call
Charles River Laboratories International, Inc. (CRL)

2023-08-09
Charles River Laboratories International, Inc. Q1 FY2023 Earnings Call
Charles River Laboratories International, Inc. (CRL)

2023-05-11
Charles River Laboratories International, Inc. Q4 FY2022 Earnings Call
Charles River Laboratories International, Inc. (CRL)

2023-02-22
Charles River Laboratories International, Inc. Q3 FY2022 Earnings Call
Charles River Laboratories International, Inc. (CRL)

2022-11-02
Charles River Laboratories International, Inc. Q2 FY2022 Earnings Call
Charles River Laboratories International, Inc. (CRL)

2022-08-03
Charles River Laboratories International, Inc. Q1 FY2022 Earnings Call
Charles River Laboratories International, Inc. (CRL)

2022-05-04